Anthera Announces Positive Outcome of Second Interim Futility Analysis in the Phase 3 RESULT Clinical Study of Sollpura Pharmaceutical Investing
Astellas and Vical Announce Top-Line Results for Phase 3 Trial of Cytomegalovirus Vaccine ASP0113 in Hematopoietic Stem Cell Transplant Recipients Biotech Investing
Nymox Reports 5-Year Results From Prospective Randomized Controlled Prostate Cancer Study of Fexapotide Triflutate Pharmaceutical Investing
AIT Therapeutics Announces Data From Its NO-NTM Abscessus Phase 2 Clinical Trial in Nontuberculous Mycobacteria Patients Pharmaceutical Investing
Novartis completes tender offer for Advanced Accelerator Applications S.A. and commencement of subsequent offering period Pharmaceutical Investing
Tonix Pharmaceuticals Announces Publication Reporting a Potential Smallpox-Preventing Vaccine Candidate Pharmaceutical Investing
CBMG Accelerates Cell Therapy Manufacturing with GE Healthcare’s New Start-to-Finish Solution Biotech Investing
